Oklo Inc. secured U.S. Department of Energy approval for the Nuclear Safety Design Agreement for its Aurora powerhouse. This agreement governs the design, construction, and operation of the company's first reactor at Idaho National Laboratory.
Subsidiary Atomic Alchemy received a U.S. Nuclear Regulatory Commission license to handle and process isotopes. This authorization supports the company's expansion into the radioisotope market.
The regulatory milestones coincide with the scheduled release of Oklo’s full-year 2025 financial results today.
Filings from March 17 show that Oklo’s CEO and CFO each sold over $4.3 million in shares on March 13. Total insider selling from the two executives exceeded $8.6 million.